The use of opioid pain medication has increased dramatically in the United States over the past two decades. That is associated with an increased risk of complications including opioid use disorder, fatal drug poisoning due to accidental overdoses or suicides in addition to a myriad of other psychological and otherwise medical conditions. Buprenorphine is a partial opioid agonist with less reinforcing properties and less abuse potential. It is commonly used for the treatment of opioid use disorder and the data shows that it effectively reduces illicit opioid use and improves treatment retention for patients with opioid use disorder and co-occurring pain. It has been found to be effective at addressing both conditions simultaneously. Its efficacy compared to opioid agonists such as morphine is unclear but probably varies with the type of pain.
Access “The Use of Buprenorphine to Treat Co-occurring Pain and Opioid Dependence in a Primary Care Setting” at: https://pcssnow.org/event/the-use-of-buprenorphine-to-treat-co-occurring-pain-and-opioid-dependence-in-a-primary-care-setting/
More information can be found at: